Antiviral treatment of hepatitis C in Serbian prison setting: Medical treatment outcomes and patients’ adherence | Zendy

Jasmina Simonovic-Babic | Zendy; Ksenija Bojović | Zendy; Dragan Delić | Zendy; Nataša Katanić | Zendy; Nikola Mitrović | Zendy; Jovan Malinic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiviral treatment of hepatitis C in Serbian prison setting: Medical treatment outcomes and patients’ adherence

Author(s) -

Jasmina Simonovic-Babic,

Ksenija Bojović,

Dragan Delić,

Nataša Katanić,

Nikola Mitrović,

Jovan Malinic

Publication year - 2016

Publication title -

medicinski pregled

Language(s) - English

Resource type - Journals

eISSN - 1820-7383

pISSN - 0025-8105

DOI - 10.2298/mpns1604085s

Subject(s) - medicine , ribavirin , pegylated interferon , hepatitis c , regimen , adverse effect , hepatitis c virus , immunology , virus

Seroprevlence of chronic hepatitis C viral infection in correctional facilities ranges from 16% to 49%. However, there are only very limited data available on the course of hepatitis C viral infection and outcomes oftreatment with pegylated interferon plus ribavirin in correctional settings. The aim ofthis study was to assess the feasibility and effectiveness of use of pegylated interferon plus ribavirin treatment in the Serbian correctional setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research